Hepatitis E serology
Extension to scope to be applied for
Hepatitis E is an illness of the liver caused by hepatitis E virus (HEV). This virus can infect both animals and humans. HEV infection is usually a mild disease and the virus infection will clear by itself. However, in individuals with suppressed immune systems, the virus can result in persistent infection which in turn can cause chronic inflammation of the liver. In rare cases, it can cause a fatal infection in pregnant women.
PURPOSE OF PROGRAMME:
To determine HEV IgM and IgG status in human serum
MATERIAL PROVIDED: Liquid human serum
DISTRIBUTIONS PER YEAR: 3
SAMPLES PER DISTRIBUTION: 4
FREQUENCY OF DISTRIBUTION: http://www.ukneqasmicro.org.uk/menu/distribution-timetable
PROGRAMME OF ANALYSIS:
Results are entered via the UK NEQAS secure website. The distribution is open for three weeks. Intended results are usually uploaded the day after the closing date. Late results are not accepted after intended results are uploaded.
Qualitative detection, consensus with intended results. General descriptive statistics.
PERSISTENT POOR PERFORMANCE:
See the Annual Directory for UK and Irish participants only
The first distribution of UK NEQAS for Microbiology was sent out by the then Public Health Laboratory Services on the 1st of May 1971 organised by Dr Peter Crone. This distribution consisted of one scheme, three bacteriology specimens, sent to 67 laboratories in the UK. One of our recent distributions consisted of 12 different schemes, comprising 8 bacteriology, 13 serology, 10 molecular and 9 mycology specimens, and sent to 53 countries representing over 1300 laboratories. UK NEQAS for Microbiology, operated by UK Health Security Agency, is a UKAS accredited proficiency testing provider No. 4715.